cereneo

What cereneo does

cereneo is a Swiss neurorehabilitation clinic group founded in 2012 and headquartered in Weggis, Switzerland, operating across multiple legal entities including cereneo Schweiz AG for clinical operations, cereneo International AG for international patient services, and cereneo Home B.V. in the Netherlands for home-based and online therapy delivery. With 101-250 employees and ISO 9001 certification, the company delivers specialized inpatient, outpatient, home, and online rehabilitation to patients recovering from neurological conditions such as stroke, Parkinson's disease, traumatic brain injury, and multiple sclerosis. Its clinical program is anchored on a capital-intensive technology stack including robotic gait and balance systems (CAREN, Lokomat, ZeroG, exoskeletons), VR-based training, non-invasive brain stimulation (tVNS via the SmartVNS partnership with Skaaltec, tDCS, TMS), wearable motion sensors, and a dedicated sleep laboratory. Research collaborations with Johns Hopkins University, KU Leuven, ETH Zurich, and the University of Zurich, alongside an in-house research institute (LLUI) and the cereneo Foundation, support evidence generation and clinical validation.

Revenue is generated through quote-based pricing across inpatient stays (long-duration, recurring), home-based rehabilitation subscriptions, online/telerehabilitation sessions, and specialized professional services, with an international patient segment sitting alongside Swiss domestic demand. Go-to-market relies on clinical reputation, physician referrals, and direct patient acquisition for international inbound flow. A related brand entity, cereneo Prevention, indicates planned extension into pre-acute or wellness-oriented services. Leadership includes Prof. Dr. med. Andreas Luft as President of the Board, Dennis Marschalleck as Managing Director of cereneo Schweiz AG, Frenske van den Dries as Managing Director of cereneo Home, Dr. Meret Branscheidt as Medical Director Hertenstein, and Shari Langemak as Director Innovation & Business Development.

Name

cereneo

Legal name

cereneo Schweiz AG

Website

https://cereneo.ch

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

cereneo is a Swiss neurorehabilitation clinic group offering high-tech inpatient, outpatient, home, and online therapy for stroke, Parkinson's, TBI, and MS patients from its Weggis-area clinics and Netherlands-based home services unit.

Ownership category

akta.pro rank

Product category

Neurorehabilitation Services

NAICS

Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Skilled Nursing Care Facilities (8051), Services-Home Health Care Services (8082), Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

Neurorehabilitation Centers (HLAFAFAH)

akta.pro secondary industries

Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH), Neurological Rehabilitation Therapy In-Home (e.g., Stroke, Parkinson’s) (HSABADAE), Stroke & Vascular Neurology (HLAKAIAG)

Keywords

• Neurorehabilitation services
• Neurological rehabilitation
• Stroke rehabilitation
• Parkinson's therapy
• Robotic gait therapy

Headquarters

HQ city

Weggis

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Inpatient Neurorehabilitation: Residential rehabilitation programs at clinic facilities in Switzerland including accommodation, meals, and comprehensive therapy services
2. Home Rehabilitation Services: Cereneo Home services including therapist home visits and online therapy sessions for patients worldwide
3. Online/Telerehabilitation: Virtual therapy sessions and online doctor consultations for remote patients
4. Specialized Therapy Services: Individual therapy sessions including physiotherapy, occupational therapy, speech therapy, neuropsychology, and nutritional counseling

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

cereneo provides personalized neurorehabilitation through inpatient clinics at Hertenstein and Vitznau, home-based rehabilitation programs via cereneo Home, and online therapy platforms. Services target patients recovering from stroke, Parkinson's disease, multiple sclerosis, traumatic brain injury, and other neurological conditions. Treatment combines intensive one-on-one therapy with advanced rehabilitation technologies including robotic gait therapy, virtual reality, and non-invasive brain stimulation.

Product overview

cereneo is a Swiss neurorehabilitation clinic offering a comprehensive, holistic approach to neurorehabilitation through three interconnected service streams: inpatient rehabilitation at its clinics in Hertenstein (Weggis) and Vitznau, home-based therapy through cereneo Home services, and online/telerehabilitation. The organization provides personalized treatment for neurological conditions including stroke, Parkinson's disease, Multiple Sclerosis, and traumatic brain injuries. cereneo integrates advanced medical technologies including robotic gait systems (CAREN, Lokomat, ZeroG, Exoskeleton), brain stimulation technologies (tDCS, TMS, tVNS/SmartVNS), wearable monitoring sensors, and digital therapeutic tools. Treatment modalities include physiotherapy, occupational therapy, speech and language therapy, neuropsychology, and psychological support, delivered by an interdisciplinary team of neurologists, therapists, nurses, engineers, and researchers.

Differentiator

Problem solved

Functional benefit

Products and services

• Inpatient Rehabilitation

Quantifiable outcome

• High-intensity therapy model with 6+ average therapy sessions per patient per day
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature11 records

Partnerships

Twelve partnerships are on record, tiered core, flagship, regional and minor.

• University of ZurichcoreStrategic or Co-development PartnerAcademic partnership for joint neuroscientific studies to advance neurorehabilitation, establish objective measurement standards, and develop new interventions and technologies.
• Lake Lucerne Institute (LLUI)coreStrategic or Co-development PartnerResearch institute partnership including Therapy Science Lab collaboration and DART group (Data Analysis and Rehabilitation Technology) for developing rehabilitation technology solutions.
• cereneo FoundationcoreStrategic or Co-development PartnerCharitable foundation supporting neurorehabilitation research initiatives and studies conducted at cereneo clinics.
• Johns Hopkins UniversityflagshipStrategic or Co-development PartnerInternational research partnership with one of the world's leading academic medical centers for advancing neurorehabilitation science.
• KU LeuvenflagshipStrategic or Co-development PartnerEuropean research university partnership contributing to cereneo's international academic network and research collaborations.
• ETH ZurichcoreTechnology or IntegrationTechnology partnership with ETH's RELab for developing rehabilitation technologies including the SmartVNS system through spin-off Skaaltec.
• University Hospital Zurich (USZ)coreChannel Partner/ Reseller/ DistributorSwiss hospital partnership for patient referrals and clinical collaboration in neurological care.
• Spital SchwyzregionalChannel Partner/ Reseller/ DistributorRegional hospital partnership for patient referrals and continuity of care in neurorehabilitation.
• Schulthess KlinikregionalChannel Partner/ Reseller/ DistributorSwiss specialist clinic partnership for orthopedic and neurological patient referrals.
• The Loop ZurichregionalStrategic or Co-development PartnerResearch hub partnership in Zurich's innovation ecosystem for technology and research collaboration.
• SkaalteccoreTechnology or IntegrationTechnology partnership with ETH RELab spin-off for SmartVNS system - AI-powered, motion-controlled tVNS device for upper extremity rehabilitation in stroke and spinal cord injury patients.
• cereneo PreventionminorOthersRelated brand entity offering prevention services, operating under separate website (cereneo-prevention.com).

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Others

• Hocoma (DIH): Swiss manufacturer of robotic rehab devices (Lokomat, Armeo) that cereneo uses; relevant adjacent peer reflecting the same robotics-enabled neurorehab thesis, on the device-vendor side.

Emerging players

• Kaia Health: Digital therapeutic platform for MSK and chronic conditions; comparable as a software-delivered home rehab alternative to cereneo's telerehabilitation and self-training app offerings.
• MindMaze: Swiss-founded neurotechnology company building digital therapeutics and VR/gaming-based rehab for stroke and brain injury — directly comparable technology stack (VR, brain stimulation, neurorehab).
• Sword Health: Digital musculoskeletal and neurological rehabilitation platform providing AI-enabled remote therapy — competes with cereneo's online/home rehabilitation arm with a tech-first, asset-light model.

Direct peers

• MediClin: German operator of inpatient rehabilitation clinics (including neurological rehab), similar multi-site specialty rehab model to cereneo with broader geographic coverage in DACH.
• RehaClinic: Swiss rehabilitation clinic group operating inpatient and outpatient rehab facilities, directly comparable to cereneo's Swiss clinic footprint and multidisciplinary rehab model.
• Burke Rehabilitation Hospital: New York-based specialty neurorehabilitation hospital for stroke, TBI, Parkinson's, and MS, comparable inpatient rehab model and patient mix to cereneo.
• Shirley Ryan AbilityLab: US-based research hospital specializing in physical medicine and neurorehabilitation for stroke, TBI, and spinal cord injury, with strong academic/research output — directly comparable in clinical mission and tech-enabled approach.

Broad incumbents

• VAMED Rehabilitation Clinics: Austrian-headquartered global healthcare provider operating post-acute and rehabilitation facilities, comparable in patient population (neurological, post-acute) but larger and more diversified.
• Helios Kliniken / Fresenius Helios: Large European private hospital group offering inpatient and rehabilitation services including neurology; comparable patient segments but operates across many specialties at much greater scale.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/cereneoclinic
• Facebookfacebook.com/cereneoclinic
• LinkedInlinkedin.com/company/cereneo

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cereneo